✦ LIBER ✦

No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting

✍ Scribed by Francis Jacob; Mara Meier; Rosmarie Caduff; Darlene Goldstein; Tatiana Pochechueva; Neville Hacker; Daniel Fink; Viola Heinzelmann-Schwarz

Book ID: 113963141
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 489 KB
Volume: 121
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.02.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differentiating stage 1 epithelial ovari

Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age

✍ Kondalsamy-Chennakesavan, Srinivas; Hackethal, Andreas; Bowtell, David; Obermair 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 168 KB

The plasma concentration of VEGF, HE4 an

The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors

✍ Sławomir Ławicki, Grażyna Ewa Będkowska… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 226 KB